SetPoint Medical Announces U.S. Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis

News SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, today announced it has launched a pilot trial for patients with drug refractory rheumatoid arthritis (RA) in the U.S.... Contributed Author: Business Wire Topics: Medical Diagnostics